Takeda has joined forces with Iambic Therapeutics on a multiyear collaboration to use the US biotech's AI-driven, structure-based drug discovery platform to find new therapies for gastrointestinal and inflammatory diseases, as well as cancer.
Healthcare innovation continues to evolve at an extraordinary pace — driven by advances in AI, digital health, virtual care, and new models of medical education.
At the centre of many of these conversations is Prof. Shafi Ahmed, our Chairman and…
Owkin and Sanofi are expanding their artificial intelligence collaboration through a multi-year agreement to co-develop AI-enabled biopharma agents for drug research and development.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us